Skip to content

    Nath Bio-Genes (India) Q4 FY26 earnings call

    NATHBIOGEN
    Fast Moving Consumer Goods·5 May 2026
    Management Summary

    Nath Bio-Genes reported a strong Q4 FY26 with 19% YoY revenue growth to INR 431.6 crores, driven by robust performance in cotton, paddy, and particularly maize. While gross margins normalized from previous highs and PAT saw an 8% decline due to increased tax rates and finance costs, the company highlighted strategic diversification, successful international expansion with its Uzbekistan JV contributing INR 15 crores, and a healthy product pipeline. Management expressed confidence in continued growth despite environmental challenges like El Nino, emphasizing a balanced portfolio and distribution network.

    Highlights

    5
    • Total revenue grew 19% YoY to INR 431.6 crores.

    • Paddy value rose 37% YoY.

    • Maize volumes surged 54% YoY, with value growth of 78%, contributing 10.72% to top line.

    • Uzbekistan JV contributed INR 15 crores to the top line, marking a landmark international expansion.

    • EPS improved to INR 23.42, more than 2X increase from INR 11.3 in FY22.

    Concerns

    4
    • Gross margin normalized to 56% from an elevated 63% in FY25.

    • PAT declined 8% YoY to INR 38.4 crores, partly due to tax rate increase from 5% to 11% and higher finance costs.

    • Plant Nutrition segment saw an 18% decline due to China export restrictions.

    • Negative cash flow of INR 1.3 crores, though management states it's not a big issue due to INR 70.7 crores in bank balances.

    Key financials

    Single quarter

    09 metrics
    1. 01Revenue₹431.6 Cr+19%YoY
    2. 02Gross Profit₹240.3 Cr+5%YoY
    3. 03Gross Margin56%
    4. 04EBITDA₹52.5 Cr
    5. 05EBITDA Margin12%

    Segment breakdown

    Cotton-Paddy Combined Portfolio
    58% Revenue Mix52% Revenue Mix FY25
    Paddy
    37% Value Growth25% Volume Growth75,619 quintals Volume
    Maize
    78% Value Growth54% Volume Growth9,639 quintals Volume10.7% Revenue Contribution
    Vegetable Seeds
    -11% Value Growth1,244 Rs/kg Average Realization6% Realization Growth
    Plant Nutrition Segment
    18% Decline
    Uzbekistan JV
    ₹15 Cr Contribution
    List

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    M&A

    Uzbekistan JV

    joint venture · integrated

    Liquidity

    Cash ₹70.7 crores

    Company has almost INR 70-80 crores of cash and bank balances.

    Guidance & targets

    5
    CategoryTargetPriority
    Revenue
    Top Line Growth
    15-20%
    Medium
    Profitability
    EBITDA Margin Trend
    Slight upward trend
    Medium
    Profitability
    Net Profit Margin Trend
    Slight upward trend
    Medium
    International Business
    Revenue from International Operations
    10-15% of top line (approx INR 150 crores if top line is INR 1000 crores)
    Medium
    Top Line
    Total Top Line
    INR 500 crores
    Low

    What to watch in Q1 FY27

    5

    Top Line Growth (FY27)

    Next quarter (for initial indications)
    Current19% YoY (FY26)
    Target15-20% YoY

    Why it matters

    Verifying if the company can achieve its stated revenue growth target for FY27, especially given market conditions.

    So, we expect the top line to be growing between 15-20% around that time, and I'm again being conservative. But 15%, hopefully💬, yes.

    Risks & concerns

    4
    RiskSeverity

    Erratic monsoons and climate change (El Nino)

    El Nino can cause crop shifts, delayed planting, and affect demand, but the company mitigates this through product diversification, geographical spread, and stock management to maintain top line.Both acknowledged

    medium

    Gross margin compression

    Gross margin normalized to 56% from an elevated 63% in FY25, attributed to a richer product/market mix and increased finance/marketing costs, though management expects a slight upward trend.Management acknowledged

    medium

    Decline in Plant Nutrition segment

    Plant Nutrition segment declined 18% due to China export restrictions, which disturbed supply dynamics, but is expected to normalize in the coming year.Management acknowledged

    low

    Negative cash flow

    A negative cash flow of INR 1.3 crores was reported, but management stated it's not a big issue given INR 70.7 crores in bank balances and strategic inventory build-up.Analyst downplayed

    low

    Q&A highlights

    8

    “as of today, INR 15 crores was only a beginning, if I can conclude that. And down the line, we have not yet put in any targets financially. Maybe by next year, the acceptability of the products will be known because whatever is sold will be grown this year. And depending upon that, maybe we will actually set up a growth target.”

    Analyst pushed for specific future targets for a new international venture, but management preferred to wait for product acceptance before committing to numbers, indicating early stage and cautious approach.

    asked by Deepesh Sancheti

    3 min read7 chapters

    Detailed Narrative

    01

    Q4 FY26 Performance Overview

    Nath Bio-Genes reported a robust Q4 FY26, with total revenue reaching INR 431.6 crores, marking a 19% year-over-year growth. This performance was driven by strong demand across its core and diversified crop segments. The company's strategic focus on growth and market penetration yielded positive results, with key products demonstrating strong farmer acceptance and product superiority.

    02

    Crop Portfolio Diversification & Growth

    The cotton-paddy combined portfolio now accounts for 58% of the revenue mix, an increase from 52% in FY25, indicating deeper penetration in core crops. Paddy value grew 37% YoY, while maize emerged as a star performer with volumes surging 54% YoY and value growing 78%, now contributing 10.72% to the top line. This validates the company's deliberate investment in high-potential categories beyond its traditional strengths, reflecting a well-balanced product portfolio.

    03

    International Expansion with Uzbekistan JV

    FY26 marked a historic milestone with the Uzbekistan joint venture contributing INR 15 crores to the consolidated top line for the first time. This achievement signifies a successful step in the company's global expansion journey. Management is cautiously optimistic💬 about replicating this model in neighboring geographies, with an aspiration for international operations to contribute 10-15% of the top line in the next three to five years, aiming for INR 150 crores if the top line reaches INR 1000 crores.

    04

    Financial Performance & Margins

    Gross profit grew 5% YoY to INR 240.3 crores, maintaining a gross margin of 56%, which normalized from an elevated 63% in FY25. EBITDA stood at INR 52.5 crores with a 12% margin, and PAT was INR 38.4 crores with a 9% margin, experiencing an 8% YoY decline partly due to an increased effective tax rate from 5% to 11% and higher finance/marketing costs. EPS improved to INR 23.42, more than doubling from INR 11.3 in FY22, reflecting sustained value creation.

    05

    Capital Allocation Strategy

    The company maintains an asset-light capital expenditure strategy, primarily investing in land bank and vehicles, while being averse to significant investments in processing plants and storages, preferring rentals for economic viability. Cash and bank balances stood at INR 70.7 crores, providing ample liquidity. Management clarified that a reported negative cash flow of INR 1.3 crores was not a significant concern, given the substantial bank balances and strategic inventory build-up.

    06

    Response to Climate Challenges (El Nino)

    Management acknowledged the persistent challenge of erratic monsoons and climate change, including El Nino. Their strategy involves balancing product offerings, sales areas, and production across diverse agroclimatic conditions to mitigate risks and ensure top-line protection. They emphasized their preparedness through advance stock placement to branches, allowing for immediate shifts in case of rainfall changes, aiming to perform better than the industry.

    07

    Inventory Management and Working Capital

    The company strategically increased inventory build-up in FY26, with total assets growing to INR 1,082.9 crores and inventory increasing to INR 444.6 crores, particularly for cotton, anticipating production stabilization and future demand. This approach, while leading to higher finance costs of INR 13.3 crores (up from INR 9.6 crores in FY25) and contributing to a negative cash flow of INR 1.3 crores, is deemed necessary to ensure product availability and meet future sales, with management asserting it will not affect working capital needs.

    This is an AI-generated summary of a publicly available earnings call transcript.